GAM
RVMD icon

Gotham Asset Management’s Revolution Medicines RVMD Stock Holding History

Gotham Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Buy
125,901
+12,072
+11% +$1.22M 0.04% 631
2025
Q4 		$9.07M Buy
113,829
+14,715
+15% +$965K 0.03% 665
2025
Q3 		$4.63M Buy
+99,114
New +$3.88M 0.02% 802

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Gotham Asset Management's RVMD Position: Q1 2026 in Review

Gotham Asset Management increased its Revolution Medicines (RVMD) stake by 11% in Q1 2026, buying an estimated $1.22M and bringing the position to 125,901 shares worth $12.2M. The position accounts for 0.04% of the portfolio, ranked #631.

Gotham Asset Management first reported a position in RVMD in Q3 2025 and has held it in 3 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Gotham Asset Management held 125,901 shares of Revolution Medicines worth $12.2M as of Q1 2026.
  • Gotham Asset Management bought 12,072 Revolution Medicines shares in Q1 2026, an estimated $1.22M.
  • Revolution Medicines made up 0.04% of Gotham Asset Management's portfolio in Q1 2026, its #631 holding.
  • Gotham Asset Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 3 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.